Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease

Authors

DOI:

https://doi.org/10.15407/dopovidi2021.04.110

Keywords:

COVID-19, type 2 diabetes, apolipoprotein A1

Abstract

Increased levels of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A1 (ApoA1) in plasma is associated with a reduced risk of developing cardiovascular diseases (CVD). In addition to its potential cardioprotective function, HDL and ApoA1, the main HDL apolipoprotein, also have antidiabetic properties. The aim of the study was to determine the level of ApoA1 in the blood of patients (n = 81) with type 2 diabetes mellitus and COVID-19. ApoA1 was determined by enzyme-linked immunosorbent assay (ELISA) (Elabscience, USA). The measurements were performed at an optical density of 450 nm. We showed that the level of ApoA1 in the blood of patients with type 2 diabetes and especially with COVID-19 was significantly lower than in the blood of healthy people. Blood ApoA1 levels did not show a further decrease in patients with both COVID-19 and diabetes compared with patients with COVID-19 without diabetes. Thus, the level of ApoA1 may be one of the promising markers of severe COVID-19.

References

Rye, K. -A., Barter, P. J. & Cochran, B. J. (2016). Apolipoprotein A-I interactions with insulin secretion and production. Curr. Opin. Lipidol., 27, No. 1, pp. 8-13. https://doi.org/10.1097/MOL.0000000000000253

Fritzen, A. M., Domingo-Espín, J., Lundsgaard, A. M., Kleinert, M., Israelsen, I., Carl, C. S., Nicolaisen, T. S., Kjøbsted, R., Jeppesen, J. F., Wojtaszewski, J. F. P., Lagerstedt, J. O. & Kiens, B. (2020). ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα2. Mol. Metab., 35, 100949. https://doi.org/10.1016/j.molmet.2020.01.013

Mao, Y., Xu, Y. & Lu, L. (2017). The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes. Medicine (Baltimore). 96, No. 1, e5834. https://doi.org/10.1097/ MD.0000000000005834. Erratum in: Medicine (Baltimore), 96, No. 12, e6541. Erratum in: Medicine (Baltimore), 96, No. 17, e6821.

Dong, H., Chen, W., Wang, X., Pi, F., Wu, Y., Pang, S., Xie, Y., Xia, F. & Zhang, Q. (2015). Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study. Metab. Brain Dis., 30, No. 6, pp. 1319-1330. https://doi.org/10.1007/s11011-015-9732-7

Sokolova, L. K. (2014). Risk factors and clinical and diagnostic aspects of cardiovascular pathology in patients with type 1 and 2 diabetes mellitus. (Extended abstract of Doctor thesis). V.P. Komisarenko State Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine (in Ukrainian).

Cochran, B. J., Ong, K. -L., Manandhar, B. & Rye, K. -A. (2021). High density lipoproteins and diabetes. Cells, 10, No. 4, 850. https://doi.org/10.3390/cells10040850

Gao, L., Zhang, Y., Wang, X. & Dong, H. (2021). Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study. BMC Endocr. Disord., 21, No. 1, 59. https://doi. org/10.1186/s12902-021-00726-5

Retnakaran, R., Ye, C., Connelly, P. W., Hanley, A. J., Sermer, M. & Zinman, B. (2019). Serum apoA1 (apolipoprotein A-1), insulin resistance, and the risk of gestational diabetes mellitus in human pregnancy — brief report. Arterioscler. Thromb. Vasc. Biol., 39, No. 10, pp. 2192-2197. https://doi.org/10.1161/ATVBAHA. 119.313195

Yang, Y., Zhu, Z., Fan, L., Ye, S., Lou, K., Hua, X., Huang, Z., Shi, Q. & Gao, G. (2020). Low serum level of apolipoprotein A1 is an indicator of severity in patients with coronavirus disease 2019. Preprint. https://doi. org/10.21203/rs.3.rs-33301/v1

Zamanian Azodi, M., Arjmand, B., Zali, A. & Razzaghi, M. (2020). Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach. Gastroenterol. Hepatol. Bed Bench., 13, No. 4, pp. 367-373. https://doi.org/10.22037/ghfbb.v13i4.2111

Downloads

Published

26.08.2021

How to Cite

Tronko, M., Cherviakova, S., Pushkarev, V., Belchina, Y., Kovzun, O., Pushkarev, V., & Sokolova, L. (2021). Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease. Reports of the National Academy of Sciences of Ukraine, (4), 110–113. https://doi.org/10.15407/dopovidi2021.04.110